{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T11:12:24Z","timestamp":1711969944818},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T00:00:00Z","timestamp":1535673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"European Union\u2019s Horizon","award":["633168"],"award-info":[{"award-number":["633168"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,28]]},"DOI":"10.1093\/ecco-jcc\/jjy128","type":"journal-article","created":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T01:07:41Z","timestamp":1535591261000},"page":"1499-1504","source":"Crossref","is-referenced-by-count":5,"title":["Integrated Care for Crohn\u2019s Disease: A Plea for the Development of Clinical Decision Support Systems"],"prefix":"10.1093","volume":"12","author":[{"given":"Nathalie Y","family":"Pauwen","sequence":"first","affiliation":[{"name":"UCL: Universit\u00e9 Catholique de Louvain \u2013 Institute of Health and Society, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edouard","family":"Louis","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology University Hospital CHU Li\u00e8ge, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corey","family":"Siegel","sequence":"additional","affiliation":[{"name":"Section of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Frederic","family":"Colombel","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Icahn Medical School at Mount Sinai, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Macq","sequence":"additional","affiliation":[{"name":"UCL: Universit\u00e9 Catholique de Louvain \u2013 Institute of Health and Society, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,8,31]]},"reference":[{"key":"key\n\t\t\t\t2018112810271216700_CIT0001","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0002","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(16)31711-1","article-title":"Crohn\u2019s disease","volume":"389","author":"Torres","year":"2017","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0003","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0140-6736(12)60026-9","article-title":"Crohn\u2019s disease","volume":"380","author":"Baumgart","year":"2012","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0004","first-page":"158","article-title":"Incidence and prevalence of Crohn\u2019s disease and its etiological influences","volume":"22","author":"Economou","year":"2009","journal-title":"Ann Gastroenterol"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0005","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","article-title":"Maintenance infliximab for Crohn\u2019s disease: the ACCENT I randomised trial","volume":"359","author":"Hanauer","year":"2002","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0006","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJMoa030815","article-title":"Infliximab maintenance therapy for fistulizing Crohn\u2019s disease","volume":"350","author":"Sands","year":"2004","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0007","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2006.11.041","article-title":"Adalimumab for maintenance of clinical response and remission in patients with Crohn\u2019s disease: the CHARM trial","volume":"132","author":"Colombel","year":"2007","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0008","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1215739","article-title":"Vedolizumab as induction and maintenance therapy for Crohn\u2019s disease","volume":"369","author":"Sandborn","year":"2013","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0009","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJMoa1602773","article-title":"Ustekinumab as induction and maintenance therapy for Crohn\u2019s disease","volume":"375","author":"Feagan","year":"2016","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0010","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa0904492","article-title":"Infliximab, azathioprine, or combination therapy for Crohn\u2019s disease","volume":"362","author":"Colombel","year":"2010","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0011","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/apt.13139","article-title":"Randomised clinical trial: deep remission in biologic and immunomodulator na\u00efve patients with Crohn\u2019s disease - a SONIC post hoc analysis","volume":"41","author":"Colombel","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0012","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1053\/j.gastro.2014.10.011","article-title":"Comparative effectiveness of immunosuppressants and biologics for inducing and maintaining remission in Crohn\u2019s disease: a network meta-analysis","volume":"148","author":"Hazlewood","year":"2015","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0013","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.pharep.2016.07.013","article-title":"Safety profile of biologic drugs in the therapy of Crohn disease: a systematic review and network meta-analysis","volume":"68","author":"Mo\u0107ko","year":"2016","journal-title":"Pharmacol Rep"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0014","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S0140-6736(09)61302-7","article-title":"Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study","volume":"374","author":"Beaugerie","year":"2009","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0015","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1053\/j.gastro.2011.06.050","article-title":"Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease","volume":"141","author":"Peyrin-Biroulet","year":"2011","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0016","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.cgh.2008.03.014","article-title":"Efficacy and safety of tumor necrosis factor antagonists in Crohn\u2019s disease: meta-analysis of placebo-controlled trials","volume":"6","author":"Peyrin-Biroulet","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0017","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1038\/ajg.2016.433","article-title":"Crohn\u2019s disease activity and concomitant immunosuppressants affect the risk of serious and opportunistic infections in patients treated with adalimumab","volume":"111","author":"Osterman","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0018","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/gutjnl-2012-303376","article-title":"Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNF\u03b1 therapy: results from the COIN study","volume":"63","author":"van der Valk","year":"2014","journal-title":"Gut"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0019","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s10198-013-0536-6","article-title":"Diffusion of pharmaceuticals: cross-country evidence of anti-TNF drugs","volume":"15","author":"Brekke","year":"2014","journal-title":"Eur J Health Econ"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0020","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2036.2009.04033.x","article-title":"Cost-effectiveness of biological therapy for Crohn\u2019s disease: Markov cohort analyses incorporating United Kingdom patient-level cost data","volume":"30","author":"Bodger","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0021","doi-asserted-by":"crossref","first-page":"e0145087","DOI":"10.1371\/journal.pone.0145087","article-title":"A systematic review of the cost-effectiveness of biologics for the treatment of inflammatory bowel diseases","volume":"10","author":"Huoponen","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0022","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1053\/j.gastro.2016.12.004","article-title":"Inflammatory bowel disease 2017: innovations and changing paradigms","volume":"152","author":"Colombel","year":"2017","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0023","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0140-6736(08)60304-9","article-title":"Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn\u2019s disease: an open randomised trial","volume":"371","author":"D\u2019Haens","year":"2008","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0024","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1016\/S0140-6736(17)32641-7","article-title":"Effect of tight control management on Crohn\u2019s disease (CALM): a multicentre, randomised, controlled phase 3 trial","volume":"390","author":"Colombel","year":"2018","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0025","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.crohns.2014.02.021","article-title":"Treating beyond symptoms with a view to improving patient outcomes in inflammatory bowel diseases","volume":"8","author":"Sandborn","year":"2014","journal-title":"J Crohns Colitis"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0026","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/ajg.2015.233","article-title":"Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target","volume":"110","author":"Peyrin-Biroulet","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0027","first-page":"CD005470","article-title":"Tailored interventions to address determinants of practice [Review]","author":"Baker","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0028","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0140-6736(17)31327-2","article-title":"Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial","volume":"390","author":"de Jong","year":"2017","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0029","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/ajg.2015.86","article-title":"Using a treat-to-target management strategy to improve the doctor\u2013patient relationship in inflammatory bowel disease","volume":"110","author":"Rubin","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0030","doi-asserted-by":"crossref","first-page":"g6670","DOI":"10.1136\/bmj.g6670","article-title":"Crohn\u2019s disease","volume":"349","author":"Kalla","year":"2014","journal-title":"BMJ"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0031","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1038\/ajg.2013.248","article-title":"Diagnostic delay in Crohn\u2019s disease is associated with a complicated disease course and increased operation rate","volume":"108","author":"Schoepfer","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0032","doi-asserted-by":"crossref","first-page":"82","DOI":"10.5694\/j.1326-5377.2006.tb00477.x","article-title":"The common problem of rare disease in general practice","volume":"185","author":"Knight","year":"2006","journal-title":"Med J Aust"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0033","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/bmj.38398.500764.8F","article-title":"Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success","volume":"330","author":"Kawamoto","year":"2005","journal-title":"BMJ"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0034","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1748-5908-6-92","article-title":"Computerized clinical decision support systems for chronic disease management: a decision-maker-researcher partnership systematic review","volume":"6","author":"Roshanov","year":"2011","journal-title":"Implement Sci"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0035","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ijmedinf.2015.01.004","article-title":"A multiple-scenario assessment of the effect of a continuous-care, guideline-based decision support system on clinicians\u2019 compliance to clinical guidelines","volume":"84","author":"Shalom","year":"2015","journal-title":"Int J Med Inform"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0036","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jclinepi.2014.02.019","article-title":"Validation of international algorithms to identify adults with inflammatory bowel disease in health administrative data from Ontario, Canada","volume":"67","author":"Benchimol","year":"2014","journal-title":"J Clin Epidemiol"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0037","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/ecco-jcc\/jjw059","article-title":"EHealth technologies in inflammatory bowel disease: a systematic review","volume":"10","author":"Jackson","year":"2016","journal-title":"J Crohns Colitis"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0038","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1001\/jama.293.10.1223","article-title":"Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review","volume":"293","author":"Garg","year":"2005","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0039","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.2105\/AJPH.2014.302164","article-title":"Effectiveness of computerized decision support systems linked to electronic health records: a systematic review and meta-analysis","volume":"104","author":"Moja","year":"2014","journal-title":"Am J Public Health"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0040","first-page":"1","article-title":"Tailoring implementation strategies for evidence-based recommendations using computerised clinical decision support systems: protocol for the development of the GUIDES tools","volume":"11","author":"Van de Velde","year":"2016","journal-title":"Implement Sci"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0041","first-page":"1064","article-title":"An assessment of the AGA and CCFA quality indicators in a sample of patients diagnosed with inflammatory bowel disease","volume":"21","author":"Tkacz","year":"2015","journal-title":"J Manag Care Spec Pharm"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0042","first-page":"61","article-title":"Patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs)","volume":"6","author":"Weldring","year":"2013","journal-title":"Health Serv Insights"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0043","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ajg.2017.9","article-title":"Fostering collaboration through creation of an IBD learning health system","volume":"112","author":"Johnson","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0044","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1016\/j.amjmed.2010.10.007","article-title":"Implementation research: a critical component of realizing the benefits of comparative effectiveness research","volume":"123","author":"Atkins","year":"2010","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0045","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/sj.clpt.6100249","article-title":"Developments in post-marketing comparative effectiveness research","volume":"82","author":"Schneeweiss","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"key\n\t\t\t\t2018112810271216700_CIT0046","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/MLR.0b013e3182408812","article-title":"Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact","volume":"50","author":"Curran","year":"2012","journal-title":"Med Care"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/12\/12\/1499\/26770400\/jjy128.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T02:15:54Z","timestamp":1571796954000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article\/12\/12\/1499\/5088069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,31]]},"references-count":46,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,8,31]]},"published-print":{"date-parts":[[2018,11,28]]}},"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjy128","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,12]]},"published":{"date-parts":[[2018,8,31]]}}}